216 related articles for article (PubMed ID: 32342084)
1. Monofunctional platinum(ii) anticancer complexes based on multidentate phenanthridine-containing ligand frameworks.
Lozada IB; Huang B; Stilgenbauer M; Beach T; Qiu Z; Zheng Y; Herbert DE
Dalton Trans; 2020 May; 49(20):6557-6560. PubMed ID: 32342084
[TBL] [Abstract][Full Text] [Related]
2. Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile.
Park GY; Wilson JJ; Song Y; Lippard SJ
Proc Natl Acad Sci U S A; 2012 Jul; 109(30):11987-92. PubMed ID: 22773807
[TBL] [Abstract][Full Text] [Related]
3. The effect of geometric isomerism on the anticancer activity of the monofunctional platinum complex trans-[Pt(NH
Zhou W; Almeqdadi M; Xifaras ME; Riddell IA; Yilmaz ÖH; Lippard SJ
Chem Commun (Camb); 2018 Mar; 54(22):2788-2791. PubMed ID: 29484327
[TBL] [Abstract][Full Text] [Related]
4. Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand.
Monroe JD; Hruska HL; Ruggles HK; Williams KM; Smith ME
PLoS One; 2018; 13(3):e0192505. PubMed ID: 29513752
[TBL] [Abstract][Full Text] [Related]
5. Using Theory To Reinterpret the Kinetics of Monofunctional Platinum Anticancer Drugs: Stacking Matters.
Veclani D; Melchior A; Tolazzi M; Cerón-Carrasco JP
J Am Chem Soc; 2018 Oct; 140(43):14024-14027. PubMed ID: 30185041
[TBL] [Abstract][Full Text] [Related]
6. The chiral potential of phenanthriplatin and its influence on guanine binding.
Johnstone TC; Lippard SJ
J Am Chem Soc; 2014 Feb; 136(5):2126-34. PubMed ID: 24417436
[TBL] [Abstract][Full Text] [Related]
7. Is the cytotoxic activity of phenanthriplatin dependent on the specific size of the phenanthridine ligand π system?
Scoditti S; Dabbish E; Sicilia E
J Inorg Biochem; 2021 Jun; 219():111447. PubMed ID: 33798829
[TBL] [Abstract][Full Text] [Related]
8. Photoactive monofunctional platinum(II) anticancer complexes of multidentate phenanthridine-containing ligands: photocytotoxicity and evidence for interaction with DNA.
Lozada IB; Gussakovsky D; Jayawardhana AMDS; McKenna SA; Zheng YR; Herbert DE
Photochem Photobiol Sci; 2023 Nov; 22(11):2587-2597. PubMed ID: 37725299
[TBL] [Abstract][Full Text] [Related]
9. Rationalization of the Superior Anticancer Activity of Phenanthriplatin: An In-Depth Computational Exploration.
Dabbish E; Russo N; Sicilia E
Chemistry; 2020 Jan; 26(1):259-268. PubMed ID: 31614021
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and biological investigation of platinum(ii) complexes with asparagusic acid derivatives as ligands.
Hildebrandt J; Trautwein R; Kritsch D; Häfner N; Görls H; Dürst M; Runnebaum IB; Weigand W
Dalton Trans; 2019 Jan; 48(3):936-944. PubMed ID: 30565617
[TBL] [Abstract][Full Text] [Related]
11. Effect of a monofunctional phenanthriplatin-DNA adduct on RNA polymerase II transcriptional fidelity and translesion synthesis.
Kellinger MW; Park GY; Chong J; Lippard SJ; Wang D
J Am Chem Soc; 2013 Sep; 135(35):13054-61. PubMed ID: 23927577
[TBL] [Abstract][Full Text] [Related]
12. DNA Intercalation Facilitates Efficient DNA-Targeted Covalent Binding of Phenanthriplatin.
Almaqwashi AA; Zhou W; Naufer MN; Riddell IA; Yilmaz ÖH; Lippard SJ; Williams MC
J Am Chem Soc; 2019 Jan; 141(4):1537-1545. PubMed ID: 30599508
[TBL] [Abstract][Full Text] [Related]
13. Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin.
Riddell IA; Johnstone TC; Park GY; Lippard SJ
Chemistry; 2016 May; 22(22):7574-81. PubMed ID: 27111128
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of two platinum(II) complexes with 2-methyl-8-quinolinol derivatives as ligands and study of their antitumor activities.
Qin QP; Wang SL; Tan MX; Liu YC; Meng T; Zou BQ; Liang H
Eur J Med Chem; 2019 Jan; 161():334-342. PubMed ID: 30384040
[TBL] [Abstract][Full Text] [Related]
15. Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: In vitro anticancer study and growth retardation effect on E. coli.
Rahman FU; Ali A; Khan IU; Duong HQ; Yu SB; Lin YJ; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2017 May; 131():263-274. PubMed ID: 28334655
[TBL] [Abstract][Full Text] [Related]
16. New minor groove covering DNA binding mode of dinuclear Pt(II) complexes with various pyridine-linked bridging ligands and dual anticancer-antiangiogenic activities.
Franich AA; Živković MD; Ilić-Tomić T; Đorđević IS; Nikodinović-Runić J; Pavić A; Janjić GV; Rajković S
J Biol Inorg Chem; 2020 May; 25(3):395-409. PubMed ID: 32162071
[TBL] [Abstract][Full Text] [Related]
17. Homo- and heteroleptic Pt(II) complexes of ONN donor hydrazone and 4-picoline: A synthetic, structural and detailed mechanistic anticancer investigation.
Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Yang B; Koppireddi S; Lin Y; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2018 Jan; 143():1039-1052. PubMed ID: 29232581
[TBL] [Abstract][Full Text] [Related]
18. Two new monofunctional platinum(II) dithiocarbamate complexes:
Imran M; Rehman ZU; Hogarth G; Tocher DA; Chaudhry GE; Butler IS; Bélanger-Gariepy F; Kondratyuk T
Dalton Trans; 2020 Nov; 49(43):15385-15396. PubMed ID: 33140800
[TBL] [Abstract][Full Text] [Related]
19. Strong in vitro and vivo cytotoxicity of novel organoplatinum(II) complexes with quinoline-coumarin derivatives.
Qin QP; Wang ZF; Huang XL; Tan MX; Zou BQ; Liang H
Eur J Med Chem; 2019 Dec; 184():111751. PubMed ID: 31593828
[TBL] [Abstract][Full Text] [Related]
20. Anticancer platinum(II) complexes bearing N-heterocycle rings.
Facchetti G; Rimoldi I
Bioorg Med Chem Lett; 2019 Jun; 29(11):1257-1263. PubMed ID: 30935797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]